Loading
Loading
Organ & Bioregulator Research · 20mg
Janoshik-tested · 10 vials per kit
Vesugen is a synthetic tripeptide bioregulator studied in preclinical research for its cardiovascular and vascular endothelial effects. Research has examined its potential to stimulate vascular cell differentiation, promote endothelial tissue regeneration, regulate collagen synthesis in vessel walls, and support vascular integrity. Studies have explored applications in cardiovascular aging and vascular disease models.
≥98%
Purity
Lyophilised
Format
2–3 wks
Arrival
Don't want to wait 3 weeks?
Check local stock — weekday same/next-day delivery available.
Need to work out your dose?
Use our reconstitution calculator — syringe units in seconds.
Research Use Only — Disclaimer
This product is intended solely as a research chemical for laboratory and scientific study purposes only. It is not approved by the TGA or any regulatory body for human or animal consumption, therapeutic use, or clinical application. The information provided on this website is for educational purposes only. Handling must be limited to suitably qualified professionals operating within applicable laws and regulations. This product is not classified as a drug, food, cosmetic, or medicinal product and must not be used or labelled as such. By purchasing, you confirm you are a qualified research professional and accept full responsibility for compliance with all relevant laws in your jurisdiction.
Vesugen
Vesugen is a synthetic tripeptide developed as a systemic vascular bioregulator in the Khavinson series. Distinct from Cardiogen (cardiac-targeted) and Vesilute (urological), Vesugen specifically targets blood vessel endothelium and smooth muscle cells, with applications in systemic vascular health research.
Proposed to act via chromatin binding in vascular endothelial and smooth muscle cells, influencing gene expression related to eNOS (endothelial nitric oxide synthase), antioxidant enzymes, extracellular matrix maintenance, and anti-inflammatory mediators. Effects on endothelial integrity and vascular reactivity have been described in aged animal models.
Research describes normalisation of vascular endothelial function, reduced oxidative stress markers, and improved microcirculation parameters in aged rodent models. Vesugen is frequently included in multi-organ bioregulator protocols alongside Cardiogen for cardiovascular longevity research.
For research reference only. All information pertains to preclinical or published human trial data. Not intended as medical advice. This product is for research use only.
Don't have supplies? Grab them while you're here.
